• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清中多个基因启动子甲基化在乙型肝炎病毒相关性肝细胞癌中的诊断价值。

Diagnostic Value of the Methylation of Multiple Gene Promoters in Serum in Hepatitis B Virus-Related Hepatocellular Carcinoma.

机构信息

Department of Laboratory Medicine, Hangzhou First People's Hospital, Hangzhou, Zhejiang 310006, China.

Hangzhou Cancer Institution, Hangzhou Cancer Hospital, Hangzhou, Zhejiang 310002, China.

出版信息

Dis Markers. 2017;2017:2929381. doi: 10.1155/2017/2929381. Epub 2017 Aug 29.

DOI:10.1155/2017/2929381
PMID:28951629
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5603249/
Abstract

This study sought to evaluate the diagnostic value of the methylation of multiple gene promoters in serum in hepatitis B virus- (HBV-) related hepatocellular carcinoma (HCC). A total of 343 participants were enrolled, including 98 patients with HCC, 75 patients with liver cirrhosis (LC), 90 patients with chronic hepatitis B (CHB), and 80 healthy individuals. , , , , , and were selected as the candidate genes. The MethyLight method was used to assay promoter methylation statuses. The diagnostic performances of markers were assessed by constructing receiver operating characteristic (ROC) curves. The prevalences of methylation for , , , , , and were 52.04%, 36.73%, 29.59%, 20.41%, 17.35%, and 11.22%, respectively. methylation completely overlapped with methylation. The area under the curve (AUC) for methylation (0.718) was better than the corresponding AUC for AFP (0.609) in distinguishing HCC from CHB. When , , , and AFP were combined, the AUC was 0.852 (95% CI = 0.796-0.908, = 0.028), and the sensitivity and specificity were 83.7% and 78.9%, respectively. In conclusion, an assay that combines methylation of the , , and gene promoters in serum and AFP could significantly improve HBV-related HCC diagnoses.

摘要

本研究旨在评估血清中多个基因启动子甲基化在乙型肝炎病毒(HBV)相关肝细胞癌(HCC)中的诊断价值。共纳入 343 名参与者,包括 98 例 HCC 患者、75 例肝硬化(LC)患者、90 例慢性乙型肝炎(CHB)患者和 80 名健康个体。选择、、、、和作为候选基因。采用 MethyLight 方法检测启动子甲基化状态。通过构建受试者工作特征(ROC)曲线评估标志物的诊断性能。甲基化的患病率分别为、、、、和,分别为 52.04%、36.73%、29.59%、20.41%、17.35%和 11.22%。甲基化完全与甲基化重叠。与 AFP 相比,甲基化的曲线下面积(AUC)(0.718)在区分 HCC 与 CHB 方面更好。当、、和 AFP 结合时,AUC 为 0.852(95%CI=0.796-0.908,=0.028),灵敏度和特异性分别为 83.7%和 78.9%。总之,联合检测血清中、、和基因启动子甲基化与 AFP 可显著提高 HBV 相关 HCC 的诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e357/5603249/b0cb5c2811dc/DM2017-2929381.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e357/5603249/b0cb5c2811dc/DM2017-2929381.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e357/5603249/b0cb5c2811dc/DM2017-2929381.001.jpg

相似文献

1
Diagnostic Value of the Methylation of Multiple Gene Promoters in Serum in Hepatitis B Virus-Related Hepatocellular Carcinoma.血清中多个基因启动子甲基化在乙型肝炎病毒相关性肝细胞癌中的诊断价值。
Dis Markers. 2017;2017:2929381. doi: 10.1155/2017/2929381. Epub 2017 Aug 29.
2
Combination of serum RASSF1A methylation and AFP is a promising non-invasive biomarker for HCC patient with chronic HBV infection.血清RASSF1A甲基化与甲胎蛋白联合检测是慢性HBV感染的肝癌患者一种很有前景的非侵入性生物标志物。
Diagn Pathol. 2015 Aug 4;10:133. doi: 10.1186/s13000-015-0317-x.
3
Methylated cysteine dioxygenase-1 gene promoter in the serum is a potential biomarker for hepatitis B virus-related hepatocellular carcinoma.血清中甲基化半胱氨酸双加氧酶-1 基因启动子是乙型肝炎病毒相关肝细胞癌的潜在生物标志物。
Tohoku J Exp Med. 2014 Mar;232(3):187-94. doi: 10.1620/tjem.232.187.
4
Hypomethylated Ubiquitin-Conjugating Enzyme2 Q1 (UBE2Q1) Gene Promoter in the Serum Is a Promising Biomarker for Hepatitis B Virus-Associated Hepatocellular Carcinoma.血清中低甲基化的泛素结合酶2 Q1(UBE2Q1)基因启动子是乙肝病毒相关肝细胞癌的一种有前景的生物标志物。
Tohoku J Exp Med. 2017 Jun;242(2):93-100. doi: 10.1620/tjem.242.93.
5
Combined detection of insulin-like growth factor-binding protein 7 promoter methylation improves the diagnostic efficacy of AFP in hepatitis B virus-associated hepatocellular carcinoma.胰岛素样生长因子结合蛋白 7 启动子甲基化的联合检测提高了 AFP 在乙型肝炎病毒相关性肝细胞癌中的诊断效能。
Pathol Res Pract. 2018 Jan;214(1):144-150. doi: 10.1016/j.prp.2017.10.004. Epub 2017 Oct 9.
6
Hypermethylation of secreted frizzled related protein 2 gene promoter serves as a noninvasive biomarker for HBV-associated hepatocellular carcinoma.分泌型卷曲相关蛋白 2 基因启动子高甲基化可作为 HBV 相关肝细胞癌的非侵入性生物标志物。
Life Sci. 2021 Apr 1;270:119061. doi: 10.1016/j.lfs.2021.119061. Epub 2021 Jan 14.
7
Diagnostic and Prognostic Roles of Serum Osteopontin and Osteopontin Promoter Polymorphisms in Hepatitis B-related Hepatocellular Carcinoma.血清骨桥蛋白及骨桥蛋白启动子多态性在乙型肝炎相关肝细胞癌中的诊断及预后作用
Asian Pac J Cancer Prev. 2015;16(16):7211-7. doi: 10.7314/apjcp.2015.16.16.7211.
8
Diagnostic Value of the Hypomethylation of the WISP1 Promoter in Patients with Hepatocellular Carcinoma Associated with Hepatitis B Virus.乙型肝炎病毒相关性肝细胞癌中 WISP1 启动子低甲基化的诊断价值。
Tohoku J Exp Med. 2020 Dec;252(4):297-307. doi: 10.1620/tjem.252.297.
9
Serum SOX11 promoter methylation is a novel biomarker for the diagnosis of Hepatitis B virus-related hepatocellular carcinoma.血清 SOX11 启动子甲基化是诊断乙型肝炎病毒相关肝细胞癌的一种新型生物标志物。
Neoplasma. 2016;63(3):419-26. doi: 10.4149/311_151029N552.
10
Hepatocellular carcinoma suppressor 1 promoter hypermethylation in serum. A diagnostic and prognostic study in hepatitis B.血清中肝细胞癌抑制因子1启动子高甲基化。一项针对乙型肝炎的诊断和预后研究。
Clin Res Hepatol Gastroenterol. 2017 Mar;41(2):171-180. doi: 10.1016/j.clinre.2016.10.003. Epub 2017 Feb 8.

引用本文的文献

1
Hepatocellular Carcinoma: The Search for an Optimal Screening Test.肝细胞癌:寻找最佳筛查检测方法
Middle East J Dig Dis. 2025 Jan;17(1):31-39. doi: 10.34172/mejdd.2025.407. Epub 2025 Jan 31.
2
Novel urine cell-free DNA methylation markers for hepatocellular carcinoma.新型肝细胞癌尿液游离 DNA 甲基化标志物。
Sci Rep. 2023 Dec 7;13(1):21585. doi: 10.1038/s41598-023-48500-y.
3
MethMarkerDB: a comprehensive cancer DNA methylation biomarker database.MethMarkerDB:一个全面的癌症 DNA 甲基化生物标志物数据库。

本文引用的文献

1
Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma.具有诊断和预后潜力的肝细胞癌无细胞甲基化标志物
Oncotarget. 2017 Jan 24;8(4):6406-6418. doi: 10.18632/oncotarget.14115.
2
DNA methylation profiling of esophageal adenocarcinoma using Methylation Ligation-dependent Macroarray (MLM).使用甲基化连接依赖宏阵列(MLM)对食管腺癌进行DNA甲基化谱分析。
Biochem Biophys Res Commun. 2016 Oct 14;479(2):231-237. doi: 10.1016/j.bbrc.2016.09.049. Epub 2016 Sep 12.
3
Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine.
Nucleic Acids Res. 2024 Jan 5;52(D1):D1380-D1392. doi: 10.1093/nar/gkad923.
4
The diagnostic value of circulating tumor DNA in hepatitis B virus induced hepatocellular carcinoma: a systematic review and meta-analysis.循环肿瘤DNA在乙型肝炎病毒所致肝细胞癌中的诊断价值:一项系统评价和荟萃分析
J Liver Cancer. 2022 Sep;22(2):167-177. doi: 10.17998/jlc.2022.09.19. Epub 2022 Sep 29.
5
Diagnostic performance of circulating tumor DNA as a minimally invasive biomarker for hepatocellular carcinoma: a systematic review and meta-analysis.循环肿瘤 DNA 作为肝细胞癌微创生物标志物的诊断性能:系统评价和荟萃分析。
PeerJ. 2022 Nov 3;10:e14303. doi: 10.7717/peerj.14303. eCollection 2022.
6
Machine Learning-based Prediction of HBV-related Hepatocellular Carcinoma and Detection of Key Candidate Biomarkers.基于机器学习的HBV相关肝细胞癌预测及关键候选生物标志物检测
Medeni Med J. 2022 Sep 21;37(3):255-263. doi: 10.4274/MMJ.galenos.2022.39049.
7
Role of Circulating Tumor DNA in Gastrointestinal Cancers: Current Knowledge and Perspectives.循环肿瘤DNA在胃肠道癌症中的作用:当前认知与展望
Cancers (Basel). 2021 Sep 22;13(19):4743. doi: 10.3390/cancers13194743.
8
Liquid Biopsy in Hepatocellular Carcinoma: Where Are We Now?肝细胞癌中的液体活检:我们目前的进展如何?
Cancers (Basel). 2021 May 10;13(9):2274. doi: 10.3390/cancers13092274.
9
Profibrotic Signaling and HCC Risk during Chronic Viral Hepatitis: Biomarker Development.慢性病毒性肝炎期间的促纤维化信号与肝癌风险:生物标志物的开发
J Clin Med. 2021 Mar 2;10(5):977. doi: 10.3390/jcm10050977.
10
Epigenetically inactivated RASSF1A as a tumor biomarker.表观遗传失活的 RASSF1A 作为肿瘤标志物。
Bosn J Basic Med Sci. 2021 Aug 1;21(4):386-397. doi: 10.17305/bjbms.2020.5219.
综述文章:分子病理流行病学在精准医学时代肿瘤性疾病和非肿瘤性疾病研究中的作用
Epidemiology. 2016 Jul;27(4):602-11. doi: 10.1097/EDE.0000000000000471.
4
Polymorphisms of a Disintegrin and Metalloproteinase with Thrombospondin Motifs 5 and Aflatoxin B1-Related Hepatocellular Carcinoma.含血小板反应蛋白基序的解聚素和金属蛋白酶5多态性与黄曲霉毒素B1相关肝细胞癌
Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):334-43. doi: 10.1158/1055-9965.EPI-15-0774. Epub 2015 Dec 16.
5
Netrin-1 promotes cell migration and invasion by down-regulation of BVES expression in human hepatocellular carcinoma.在人类肝细胞癌中,Netrin-1通过下调BVES表达促进细胞迁移和侵袭。
Am J Cancer Res. 2015 Mar 15;5(4):1396-409. eCollection 2015.
6
Correlation of gene methylation in surgical margin imprints with locoregional recurrence in head and neck squamous cell carcinoma.头颈部鳞状细胞癌手术切缘印记中基因甲基化与局部区域复发的相关性
Cancer. 2015 Jun 15;121(12):1957-65. doi: 10.1002/cncr.29303. Epub 2015 Mar 13.
7
Methylated DNA and high total DNA levels in the serum of patients with breast cancer following neoadjuvant chemotherapy are predictive of a poor prognosis.新辅助化疗后乳腺癌患者血清中甲基化DNA和高总DNA水平预示预后不良。
Oncol Lett. 2014 Jul;8(1):397-403. doi: 10.3892/ol.2014.2068. Epub 2014 Apr 15.
8
Frequent methylation of HOXA9 gene in tumor tissues and plasma samples from human hepatocellular carcinomas.HOXA9 基因在人肝癌组织和血浆样本中的频繁甲基化。
Clin Chem Lab Med. 2014 Aug;52(8):1235-45. doi: 10.1515/cclm-2013-0780.
9
Analysis of BRAF(V600E) mutation and DNA methylation improves the diagnostics of thyroid fine needle aspiration biopsies.分析 BRAF(V600E) 突变和 DNA 甲基化可提高甲状腺细针抽吸活检的诊断准确性。
Diagn Pathol. 2014 Mar 3;9:45. doi: 10.1186/1746-1596-9-45.
10
DNA methylation as clinically useful biomarkers-light at the end of the tunnel.DNA 甲基化作为具有临床应用价值的生物标志物——隧道尽头的光。
Pharmaceuticals (Basel). 2012 Jan 18;5(1):94-113. doi: 10.3390/ph5010094.